Cholesterol can activate the PI3K/AKT pathway by binding to and stabilizing receptor tyrosine kinase (RTK), particularly epidermal growth factor receptor (EGFR) and ErbB2, which are overexpressed in many cancers [52]. The gene discussed is EGFR; the disease is cancer.